Viveve Reports Third Quarter 2018 Financial Results
November 08, 2018 16:02 ET
|
Viveve Medical, Inc.
Continued commercial growth for Viveve® System including record quarter of treatment tip sales Significant advancement of clinical programs targeting new indications in sexual function and stress...
Viveve to Host Conference Call to Discuss Third Quarter 2018 Financial and Operating Results
November 01, 2018 08:28 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that it will report...
Viveve to Present at Ladenburg Thalmann 2018 Healthcare Conference
September 25, 2018 08:28 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief...
Viveve Appoints Two New Independent Board Members
September 13, 2018 08:28 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced that Steve Basta and Karen...
Viveve Submits Investigational Device Exemption to FDA to Conduct LIBERATE-U.S. Trial for Improvement of Stress Urinary Incontinence
September 11, 2018 08:28 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced submission of an...
Viveve to Present at 20th Annual Rodman & Renshaw Global Investment Conference
August 28, 2018 08:28 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott...
Viveve Initiates LIBERATE-International Trial for Improvement of Stress Urinary Incontinence
August 14, 2018 08:28 ET
|
Viveve Medical, Inc.
Company also receives regulatory clearance in Argentina for treatment of urinary incontinence Confirms intent to submit IDE to FDA for LIBERATE-U.S. in the third quarter ENGLEWOOD, Colo., Aug. 14,...
Viveve Reports Second Quarter 2018 Financial Results and Provides Corporate Update
August 09, 2018 16:02 ET
|
Viveve Medical, Inc.
Company reports 80% growth in total quarterly revenue year-over-yearMultiple clinical and regulatory milestones achieved for Viveve® System ENGLEWOOD, Colo., Aug. 09, 2018 (GLOBE NEWSWIRE) --...
Viveve Announces FDA Approval to Continue VIVEVE II Clinical Study
August 07, 2018 08:28 ET
|
Viveve Medical, Inc.
Agency determines one-month safety data sufficient in first-stage and grants continued enrollment of up to 100 subjects in second stage of sexual function trial ENGLEWOOD, Colo., Aug. 07, 2018...
Viveve to Announce Financial Results for Second Quarter 2018 and Host Conference Call
August 02, 2018 08:28 ET
|
Viveve Medical, Inc.
ENGLEWOOD, Colo., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, will announce financial results for the...